Ovarian tissue cryopreservation can be combined simultaneously with oocyte retrieval after controlled ovarian hyperstimulation.

In vitro maturation Cancer Controlled ovarian hyperstimulation Fertility preservation Oncology Oocyte Ovarian tissue cryopreservation

Journal

Human reproduction (Oxford, England)
ISSN: 1460-2350
Titre abrégé: Hum Reprod
Pays: England
ID NLM: 8701199

Informations de publication

Date de publication:
02 05 2023
Historique:
received: 29 07 2021
revised: 13 02 2023
medline: 3 5 2023
pubmed: 3 3 2023
entrez: 2 3 2023
Statut: ppublish

Résumé

Can ovarian tissue cryopreservation (OTC) be performed after controlled ovarian hyperstimulation (COH)? Unilateral oophorectomy after transvaginal oocyte retrieval is feasible on stimulated ovaries during one surgical step. In the fertility preservation (FP) field, the timeframe between patient referral and start of curative treatment is limited. Combining oocyte pick-up with ovarian tissue (OT) extraction has been reported to improve FP but COH applied before OT extraction is not currently recommended. This retrospective cohort-controlled study involved 58 patients who underwent oocyte cryopreservation immediately followed by OTC between September 2009 and November 2021. The exclusion criteria were a delay between oocyte retrieval and OTC of >24 h (n = 5) and IVM of oocytes obtained ex vivo in the ovarian cortex (n = 2). This FP strategy was performed either after COH (stimulated group, n = 18) or after IVM (unstimulated group, n = 33). Oocyte retrieval followed by OT extraction on the same day was performed either without previous stimulation or after COH. Adverse effects of surgery and ovarian stimulation, mature oocyte yield and pathology findings of fresh OT were retrospectively analysed. Thawed OTs were analysed prospectively, for vascularization and apoptosis using immunohistochemistry, when patient consent was obtained. No surgical complication occurred after OTC surgery in either group. In particular, no severe bleeding was associated with COH. The number of mature oocytes obtained increased after COH (median = 8.5 (25% = 5.3-75% = 12.0)) compared to the unstimulated group (2.0 (1.0-5.3), P < 0.001). Neither ovarian follicle density nor cell integrity was affected by COH. Fresh OT analysis showed congestion in half of the stimulated OT which was higher than in the unstimulated OT (3.1%, P < 0.001). COH also increased haemorrhagic suffusion (COH + OTC: 66.7%; IVM + OTC: 18.8%, P = 0.002) and oedema (COH + OTC: 55.6%; IVM + OTC: 9.4%, P < 0.001). After thawing, the pathological findings were similar between both groups. No statistical difference in the number of blood vessels was observed between the groups. The oocyte apoptotic rate in thawed OT was not statistically different between the groups (ratio of positive cleaved caspase-3 staining oocytes/total number of oocytes equal to median 0.50 (0.33-0.85) and 0.45 (0.23-0.58) in unstimulated and stimulated groups respectively, P = 0.720). The study reports FP from a small number of women following OTC. Follicle density and other pathology findings are an estimate only. Unilateral oophorectomy can be successfully performed after COH with limited bleeding risk and an absence of impact on thawed OT. This approach could be proposed to post pubertal patients when the number of mature oocytes expected is low or when the risk of residual pathology is high. The reduction of surgical steps for cancer patients also has positive implications for introducing this approach into clinical practice. This work was made possible through the support of the reproductive department of Antoine-Béclère Hospital and of the pathological department of Bicêtre Hospital (Assistance Publique Hôpitaux de Paris, France). The authors have no conflict of interest to disclose in this study. N/A.

Identifiants

pubmed: 36860186
pii: 7067054
doi: 10.1093/humrep/dead041
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

860-871

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Vincent Puy (V)

Université Paris-Saclay, Assistance Publique Hôpitaux de Paris, Hôpital Béclère, Service de Biologie de la Reproduction CECOS, Clamart, France.
Laboratoire de Développement des Gonades, UMRE008 Stabilité Génétique Cellules Souches et Radiations, Université de Paris, Université Paris-Saclay, CEA, Fontenay-aux-Roses, France.
Service d'Histologie-Embryologie-Cytogénétique-CECOS, Centre Hospitalier Universitaire Jean-Verdier, AP-HP, Bondy, France.

Margot Dupeux (M)

AP-HP, Hôpital Bicêtre, Université Paris-Saclay, Service d'anatomopathologie, Le Kremlin Bicêtre, France.

Anne Mayeur (A)

Université Paris-Saclay, Assistance Publique Hôpitaux de Paris, Hôpital Béclère, Service de Biologie de la Reproduction CECOS, Clamart, France.

Michael Grynberg (M)

Université Paris-Saclay, Assistance Publique Hôpitaux de Paris, Hôpital Béclère, Service de Médecine de la Reproduction et Préservation de la Fertilité, Clamart, France.

Alexandra Benoit (A)

Université Paris-Saclay, Assistance Publique Hôpitaux de Paris, Hôpital Béclère, Service de Médecine de la Reproduction et Préservation de la Fertilité, Clamart, France.

Marion Bendayan (M)

Service de Biologie de la Reproduction-Andrologie-CECOS, Hôpital de Poissy-Saint Germain en Laye, Poissy, France.
Université Paris-Saclay, UVSQ, INRAE, BREED, Jouy-en-Josas, France.
ENVA, BREED, Maison-Alfort, France.

Fayçal Zhegari (F)

Université Paris-Saclay, Assistance Publique Hôpitaux de Paris, Hôpital Béclère, Service de Médecine de la Reproduction et Préservation de la Fertilité, Clamart, France.

Laetitia Hesters (L)

Université Paris-Saclay, Assistance Publique Hôpitaux de Paris, Hôpital Béclère, Service de Biologie de la Reproduction CECOS, Clamart, France.

Vanessa Gallot (V)

Université Paris-Saclay, Assistance Publique Hôpitaux de Paris, Hôpital Béclère, Service de Médecine de la Reproduction et Préservation de la Fertilité, Clamart, France.

Sophie Prevot (S)

AP-HP, Hôpital Bicêtre, Université Paris-Saclay, Service d'anatomopathologie, Le Kremlin Bicêtre, France.

Nelly Frydman (N)

Université Paris-Saclay, Assistance Publique Hôpitaux de Paris, Hôpital Béclère, Service de Biologie de la Reproduction CECOS, Clamart, France.
Laboratoire de Développement des Gonades, UMRE008 Stabilité Génétique Cellules Souches et Radiations, Université de Paris, Université Paris-Saclay, CEA, Fontenay-aux-Roses, France.

Charlotte Sonigo (C)

Université Paris-Saclay, Assistance Publique Hôpitaux de Paris, Hôpital Béclère, Service de Médecine de la Reproduction et Préservation de la Fertilité, Clamart, France.
Université Paris Saclay, Inserm, Physiologie et Physiopathologie Endocrinienne, Le Kremlin-Bicêtre, France.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH